Yu R. Plea to radiologists: Please consider Mahvash disease when encountering an enlarged pancreas. World J Radiol 2024; 16(8): 371-374 [DOI: 10.4329/wjr.v16.i8.371]
Corresponding Author of This Article
Run Yu, MD, PhD, Professor, Division of Endocrinology, Diabetes, and Metabolism, University of California at Los Angeles, David Geffen School of Medicine, 200 Medical Plaza Driveway 530, Los Angeles, CA 90095, United States. runyu@mednet.ucla.edu
Research Domain of This Article
Radiology, Nuclear Medicine & Medical Imaging
Article-Type of This Article
Letter to the Editor
Open-Access Policy of This Article
This article is an open-access article which was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution Non Commercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/licenses/by-nc/4.0/
Run Yu, Division of Endocrinology, Diabetes, and Metabolism, University of California at Los Angeles, David Geffen School of Medicine, Los Angeles, CA 90095, United States
Conflict-of-interest statement: The authors declare that they have no conflict of interest.
Open-Access: This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: https://creativecommons.org/Licenses/by-nc/4.0/
Corresponding author: Run Yu, MD, PhD, Professor, Division of Endocrinology, Diabetes, and Metabolism, University of California at Los Angeles, David Geffen School of Medicine, 200 Medical Plaza Driveway 530, Los Angeles, CA 90095, United States. runyu@mednet.ucla.edu
Received: March 25, 2024 Revised: August 15, 2024 Accepted: August 19, 2024 Published online: August 28, 2024 Processing time: 156 Days and 8.1 Hours
Abstract
Radiologists play a key role in establishing an early and accurate diagnosis, especially for rare diseases. Mahvash disease (OMIM 619290) is an autosomal recessive hereditary disease caused by inactivating mutations of the glucagon receptor and its main clinical consequences are pancreatic neuroendocrine tumors and in some cases, porto-sinusoidal vascular disease and portal hypertension. Untreated Mahvash disease can be lethal. The diagnosis of Mahvash disease has almost always been delayed in the past due to radiologists’ unawareness of or unfamiliarity with the unique imaging features of Mahvash disease which are moderately to enormously enlarge pancreas with preserved pancreas contour and parenchyma without vascular involvement or lymphadenopathy. These features help differentiate Mahvash disease from other etiologies of diffusely enlarged pancreas such as diffuse pancreatic ductal carcinoma, diffuse pancreatic lymphoma, and autoimmune pancreatitis. Invoking Mahvash disease in the differential diagnosis of an enlarged pancreas has recently been shown to facilitate early diagnosis. To prevent missing the diagnosis of this significant disease, I sincerely ask radiologists to consider Mahvash disease in their differential diagnoses of diffusely enlarged pancreas.
Core Tip: Mahvash disease is a potentially lethal, autosomal recessive hereditary disease of pancreatic neuroendocrine tumors and inborn error of metabolism. The diagnosis of Mahvash disease has been delayed in the past largely due to radiologists’ unawareness of or unfamiliarity with the unique imaging features of Mahvash disease. On the other hand, Mahvash disease can be readily diagnosed once its imaging features are appreciated. To prevent missing the diagnosis of this interesting disease, radiologists should consider Mahvash disease in their differential diagnoses of diffusely enlarged pancreas.
Citation: Yu R. Plea to radiologists: Please consider Mahvash disease when encountering an enlarged pancreas. World J Radiol 2024; 16(8): 371-374
Radiologists play a key role in establishing an early and accurate diagnosis[1]. Radiologists’ role in diagnosing rare diseases is particularly important as some rare diseases exhibit quite unique imaging features that few other diseases would share so that radiologists can make an early call of the rare diseases in the imaging differential diagnosis[2]. If the attending radiologist is not aware of the imaging features of a rare disease, however, the rare disease will not be listed in the differential diagnosis thus a cognitive diagnostic error ensues[3]. This kind of cognitive imaging diagnostic error is especially common in the imaging diagnosis of new and rare diseases, such as the Mahvash disease (OMIM 619290).
The Mahvash disease is an autosomal recessive hereditary disease caused by inactivating mutations of the glucagon receptor[4]. It was first reported in 2008[4]. Approximately 15 cases of confirmed Mahvash disease have been described so far including a recent high-profile case published in the NEJM[5,6]. The Mahvash disease is characterized by hyperglucagonemia without glucagonoma syndrome, hyperaminoacidemia, pancreatic α cell hyperplasia, and pancreatic neuroendocrine tumors[4]. Severe Mahvash disease with complete loss of glucagon receptor activity can cause porto-sinusoidal vascular disease and portal hypertension which are curable by liver transplant[5,6]. The Mahvash disease is thus both a hereditary tumor syndrome and an inborn error of metabolism. Untreated Mahvash disease can be lethal[4].
The diagnosis of Mahvash disease has almost always been delayed. Patients with Mahvash disease most frequently present with vague abdominal symptoms so they receive abdominal imaging[4]. Since its discovery, the first suspicion of Mahvash disease has been largely based on imaging findings suggestive of pancreatic neuroendocrine tumors. Laboratory testing of pancreatic hormones then reveals massive hyperglucagonemia. In the absence of glucagonoma syndrome, the diagnosis of Mahvash disease is invoked. If glucagon is not tested, the diagnosis of Mahvash disease is missed, which has happened in a number of potential but likely cases of Mahvash disease; in all these cases, typical imaging features of Mahvash disease are clearly present but Mahvash disease is not considered by radiologists[7-11].
To prevent missing such a significant and lethal disease, I make a plea to radiologists here to please consider Mahvash disease when they encounter its imaging features. The imaging features of Mahvash disease are quite unique and include diffusely enlarged pancreas with or without pancreatic masses[4]. The diffuse pancreatic enlargement is due to expansion of both endocrine (mainly α cells) and exocrine (mainly acinar cells) components of the pancreas and distributes evenly throughout the pancreas[4]. The diffuse pancreatic enlargement can be enormous and may be accompanied by single or multiple lesions of pancreatic neuroendocrine tumors (Figure 1). In the early stage of Mahvash disease, such lesions may be absent. Multiple punctate calcifications are frequently found in the pancreas (Figure 1). Other abdominal organs are grossly normal on imaging in Mahvash disease.
Figure 1 Pancreas in Mahvash disease, axial view of computed tomography with enhancement.
Note the enormously and evenly enlarged pancreas with normal pancreatic contour. Also note the multiple punctate calcifications in the pancreas.
Needless to say, Mahvash disease cannot be diagnosed based on imaging features alone and diffuse enlargement of pancreas can be seen in other pancreatic diseases such as diffuse pancreatic ductal adenocarcinoma, diffuse pancreatic lymphoma, and autoimmune pancreatitis[12-14]. Several distinct differences of these entities on imaging provide valuable clues to the differential diagnosis (Table 1). The pancreas enlargement can be enormous and but always even with preserved normal pancreatic contour in Mahvash disease while the degree of pancreatic enlargement is less extensive with loss of the normal pancreatic contour (sausage-shape) in the other 3 diseases. The pancreas parenchyma in Mahvash disease enhances normally while the other 3 conditions enhances less than the normal pancreas in the arterial phase. Diffuse pancreatic ductal carcinoma and autoimmune pancreatitis can exhibit a rim while Mahvash disease and diffuse lymphoma don’t. Peripancreatic vascular involvement and lymphadenopathy are usually not present in Mahvash disease but exist to various degrees in the others. Finally, Mahvash disease, diffuse pancreatic ductal adenocarcinoma, and diffuse pancreatic lymphoma usually don’t have extra-pancreatic manifestations while autoimmune pancreatitis often is associated with lesions in many other organs[12-14].
Table 1 Comparison of pancreas imaging features of Mahvash disease, diffuse pancreatic ductal carcinoma, diffuse pancreatic lymphoma, and autoimmune pancreatitis.
Pancreas imaging features
Mahvash disease
Diffuse pancreatic ductal carcinoma
Diffuse pancreatic lymphoma
Autoimmune pancreatitis
Pancreatic size
Moderately to enormously enlarged
Slightly enlarged
Moderately enlarged
Moderately enlarged
Pancreas contour
Preserved
Lost (sausage-shaped)
Lost (sausage-shaped)
Lost (sausage-shaped)
Pancreas parenchyma
Normal
Hypo enhancing relative to normal pancreas
Hypo enhancing relative to normal pancreas
Hypo enhancing relative to normal pancreas
Pancreatic rim
No
Enhancing rim in some patients
No
Hypo enhancing rim
Pancreatic mass
None or single or multiple lesions
No
No
None or single or multiple enhancing lesions
Vascular involvement
No
Yes
Yes
Yes
Lymphadenopathy
No
Yes in some patients
Yes
Yes
Extra pancreatic organs involvement
No
No
No
Yes
Although Mahvash disease is rare, it can be readily singled out if the unique imaging features of Mahvash disease are appreciated. In a recent series of 245 cases of diffuse pancreatic enlargement, 55% of cases were due to autoimmune pancreatitis, 36% were due to diffuse pancreatic ductal carcinoma, 2% were due to diffuse pancreatic lymphoma, and 5% were due to diffuse pancreatic neuroendocrine tumors[15]. I wrote a letter to the journal where this series was published and suggested that Mahvash disease can be present among the patients with diffuse pancreatic neuroendocrine tumors. Lo and behold, the authors of the series subsequently identified a case of Mahvash disease in their series, which is the first case of Mahvash disease in their home country and is caused by novel glucagon receptor mutations[16]. Thus 1 in 245 cases of diffuse pancreatic enlargement can be caused by Mahvash disease. The yield of identifying Mahvash disease will be much higher after radiologists integrate the nuanced imagining features of Mahvash disease, diffuse pancreatic ductal carcinoma, diffuse pancreatic lymphoma, and autoimmune pancreatitis.
In summary, Mahvash disease is a potentially lethal, autosomal recessive hereditary disease of pancreatic neuroendocrine tumors and inborn error of metabolism. The diagnosis of Mahvash disease has been delayed in the past largely due to radiologists’ unawareness of or unfamiliarity with the unique imaging features of Mahvash disease. On the other hand, a recent example shows that Mahvash disease can be readily diagnosed once its imaging features are appreciated. To prevent missing the diagnosis of this remarkable disease, I make a plea to radiologists to please consider Mahvash disease in their differential diagnoses of diffusely enlarged pancreas.
Footnotes
Provenance and peer review: Invited article; Externally peer reviewed.
Peer-review model: Single blind
Specialty type: Radiology, nuclear medicine and medical imaging
Country of origin: United States
Peer-review report’s classification
Scientific Quality: Grade B
Novelty: Grade B
Creativity or Innovation: Grade B
Scientific Significance: Grade B
P-Reviewer: Suvvari TK S-Editor: Fan M L-Editor: A P-Editor: Chen YX
Zhang L, Wen X, Li JW, Jiang X, Yang XF, Li M. Diagnostic error and bias in the department of radiology: a pictorial essay.Insights Imaging. 2023;14:163.
[PubMed] [DOI][Cited in This Article: ][Reference Citation Analysis (0)]
Robbins J, Halegoua-DeMarzio D, Basu Mallick A, Vijayvergia N, Ganetzky R, Lavu H, Giri VN, Miller J, Maley W, Shah AP, DiMeglio M, Ambelil M, Yu R, Sato T, Lefler DS. Liver Transplantation in a Woman with Mahvash Disease.N Engl J Med. 2023;389:1972-1978.
[PubMed] [DOI][Cited in This Article: ][Cited by in Crossref: 1][Reference Citation Analysis (0)]
Zorgdrager M, Cuperus FJC, de Haas RJ. Hyperammonemic Encephalopathy in a Patient with Pancreatic Neuroendocrine Tumor and Portosystemic Shunt.Diagnostics (Basel). 2023;13.
[PubMed] [DOI][Cited in This Article: ][Reference Citation Analysis (0)]
Huynh KN, Kong MJ, Nguyen BD. Anatomic and Functional Imaging of Immunoglobulin G4-related Disease and Its Mimics.Radiographics. 2023;43:e220097.
[PubMed] [DOI][Cited in This Article: ][Reference Citation Analysis (0)]